|
|
|
Biopharmaceuticals News Roundup: September 7, 2010
Protalix BioTherapeutics Names Tzvi Palash Chief Operating Officer
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, Personnel
[Protalix BioTherapeutics]
|
Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
HSMN NewsFeed,
3 Sep 2010:
Biopharmaceuticals, Oncology
[Celldex Therapeutics, Pfizer, Pfizer Vaccines, rindopepimut]
|
Gilead Sciences Submits European Marketing Application for Once-Daily Single-Tablet Regimen of Truvada(R) and TMC278 for the Treatment of HIV Infection
HSMN NewsFeed,
3 Sep 2010:
Biopharmaceuticals, HIV/AIDS
[Gilead Sciences, Tibotec Pharmaceuticals, Truvada]
|
Santhera and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease
HSMN NewsFeed,
3 Sep 2010:
Biopharmaceuticals, Neurology, Licensing
[Ipsen, Santhera Pharmaceuticals, fipamezole, dyskinesia, Parkinson’s Disease]
|
Pfizer to Acquire FoldRx Pharmaceuticals
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Pfizer, FoldRx Pharmaceuticals]
|
Celator(R) Pharmaceuticals Raises $20 Million in Series D Financing
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Venture Capital
[Celator Pharmaceuticals]
|
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Regulatory
[Archimedes Pharma, PecFent, fentanyl nasal spray, breakthrough cancer pain]
|
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Personnel
[Inspire Pharmaceuticals]
|
Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Ophthalmology
[ThromboGenics, microplasmin, vitreomacular adhesion]
|
Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients
HSMN NewsFeed,
31 Aug 2010:
Biopharmaceuticals, Ophthalmology, FDA
[Allergan, LUMIGAN, bimatoprost, intraocular pressure, glaucoma]
|
Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
HSMN NewsFeed,
31 Aug 2010:
Biopharmaceuticals
[J&JPRD, Johnson & Johnson, rivaroxaban, venous thromboembolism, DVT]
|
Meda acquires Alaven, a US specialty pharma company
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Meda AB, Alaven]
|
Otonomy Closes $38.5 Million Series B Financing
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Venture Capital
[Otonomy]
|
King Pharmaceuticals Appoints Jeffrey Bailey Chief Commercial Officer
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Personnel
[King Pharmaceuticals]
|
Genzyme Confirms Receipt of Unsolicited Proposal
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Genzyme, Sanofi-Aventis]
|
Easton Pharmaceuticals Inc. Announces Experienced CFO Appointment to Management Team
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Personnel
[Easton Pharmaceuticals]
|
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Neurology
[Sanofi-aventis, multiple sclerosis, teriflunomide, TEMSO trial]
|
sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
HSMN NewsFeed,
29 Aug 2010:
Biopharmaceuticals, Mergers & Acquisitions
[sanofi-aventis, Genzyme]
|
Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
HSMN NewsFeed,
27 Aug 2010:
Biopharmaceuticals, Cardiology, FDA
[Novartis Pharmaceuticals, aliskiren, amlodipine, Tekamlo]
|
Genentech Provides Update on FDA Application for T-DM1
HSMN NewsFeed,
27 Aug 2010:
Biopharmaceuticals, Oncology, FDA
[Genentech, Roche Group, trastuzumab-DM1, T-DM1, HER2, armed antibody]
|
XOMA Appoints Jack L. Wyszomierski to Its Board of Directors
HSMN NewsFeed,
26 Aug 2010:
Biopharmaceuticals, Personnel
[XOMA]
|
Celgene Corporation Announces Appointment of Jacqualyn A. Fouse as Senior Vice President and Chief Financial Officer
HSMN NewsFeed,
26 Aug 2010:
Biopharmaceuticals, Personnel
[Celgene]
|
Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI(R) (epoprostenol for injection) for Pulmonary Arterial Hypertension
HSMN NewsFeed,
25 Aug 2010:
Biopharmaceuticals, FDA
[Actelion Pharmaceuticals, VELETRI , epoprostenol, PAH]
|
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation
HSMN NewsFeed,
25 Aug 2010:
Biopharmaceuticals, Cardiology
[Bristol-Myers Squibb, Pfizer, AVERROES Trial, apixaban, atrial fibrillation]
|
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
HSMN NewsFeed,
25 Aug 2010:
Biopharmaceuticals
[Somaxon Pharmaceuticals, Procter & Gamble, Silenor, doxepin]
|
Celsion Receives Fast Track Designation for ThermoDox(R) Development Program to Treat Primary Liver Cancer
HSMN NewsFeed,
24 Aug 2010:
Biopharmaceuticals, Drug Delivery, Oncology, FDA
[Celsion, ThermoDox, doxorubicin, Liver Cancer]
|
|
<<
Older Biopharmaceuticals Stories
Current Newsfeed >>
|
|
|
Public
Feeds 
Full text >>